Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dendritic cells--strong candidates for immunotherapy].

F Lund-Johansen1, J Olweus

  • 1DNAX Research Institute for Cellular and Molecular Immunology, Palo Alto, CA 94306, USA. Fridtjof.Lund-Johansen@ffi.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|July 30, 1999
PubMed
Summary

Dendritic cells initiate immune responses, directing them against pathogens or malignant cells. Harnessing dendritic cell functions shows promise for cancer vaccines and treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An adjusted droplet digital PCR assay for quantification of vector copy number in CAR-T cell and TCR-T cell products.

Immuno-oncology technology·2025
Same author

Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34(+) Cells in Multiple Myeloma Patients.

Hematology (Amsterdam, Netherlands)·2016
Same author

Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Clinical and experimental immunology·2013
Same author

Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif.

Leukemia·2010
Same author

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.

Scandinavian journal of immunology·2009
Same author

The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.

Scandinavian journal of immunology·2008

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Context:

  • Investigating the mechanisms of immune response initiation.
  • Exploring the potential of dendritic cells in immunotherapy.
  • Bridging basic science discoveries with clinical applications.

Purpose:

  • To review the role of dendritic cells in directing immune responses.
  • To explore how dendritic cells can be manipulated for therapeutic purposes, particularly against cancer.
  • To highlight the translation of dendritic cell research into clinical trials.

Summary:

  • Dendritic cells capture and present antigens to T-cells in lymphoid tissues, initiating adaptive immune responses.
  • These cells can selectively target infectious agents and have shown potential in cancer vaccines, inducing tumor-specific immunity and remission.

Related Experiment Videos

  • Research indicates distinct dendritic cell subpopulations with specialized functions, underscoring their central role in immune regulation.

    • Impact:

    • Dendritic cell-based therapies offer a promising avenue for treating diseases like cancer.
    • Understanding dendritic cell biology can lead to novel strategies for immune system manipulation.
    • The rapid application of basic science findings in clinical trials accelerates therapeutic development.